Syngene International Ltd.
Healthcare
TPG-backed firm to absorb Indian drugmaker's contract development biz, go public
An Indian biopharmaceutical company that counts private equity firm TPG as an investor will absorb a local drugmaker’s contract development ......
Healthcare
Advent may rope in new investor for Bharat Serums with neat valuation markup
Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......
Healthcare
Temasek bets on another Indian healthcare company
Singapore state investment firm Temasek Holdings has picked up a minority stake in an Indian drug research company, thereby increasing ......
Healthcare
True North makes partial exit from drug research firm with strong gains
Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains ......
Healthcare
Syngene names AstraZeneca's Jonathan Hunt CEO
Syngene International Ltd, the research and development unit of biopharmaceutical firm Biocon Ltd, said on Monday it has appointed Jonathan ......
Healthcare
IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain
Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, made a strong debut on the ......
Healthcare
IVFA-backed Syngene's IPO oversubscribed 31 times
Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, saw its initial public offer (IPO) ......
Healthcare
Singapore's GIC comes as anchor investor in Syngene; IPO fully covered on day 2
Singapore's GIC, one of the most active sovereign wealth funds in the country, is among the anchor investors which have ......
Healthcare
Biocon to open IPO of R&D arm Syngene end of this month, fixes price band
Biopharmaceutical major Biocon Ltd has fixed the price band for the initial public offering (IPO) of its research and development ......
Consumer
SEBI clears Prabhat Dairy, Syngene International IPO plans
The capital markets regulator Securities and Exchange Board of India (SEBI) has given its approval to the proposed initial public ......
